-+ 0.00%
-+ 0.00%
-+ 0.00%

ENTERA BIO ANNOUNCES NEW DATA SUPPORTING FURTHER DEVELOPMENT OF A PROPRIETARY FIRST-IN-CLASS ORAL, LONG-ACTING PTH TABLET FOR PATIENTS WITH HYPOPARATHYROIDISM (EB612 PROGRAM)

路透·12/22/2025 13:30:02

登錄查看新聞詳情